-
A novel T-cell inhibitor has been approved for the treatment of rheumatoid arthritis. Abatacept is the first selective modulator of a costimulatory signal involved in T-cell activation (costimulatory blocker).
-
-
Today, advanced treatment with highly active antiretroviral therapy (HAART) has pushed back the development of AIDS in many HIV-positive patients. Consequently, more people are living longer with HIV infection, increasing the likelihood that patients will present to the emergency department (ED) at some time during the course of their illness.
-
-
-
There is a wide variation in the rate of coronary heart disease (CHD) in diabetes, depending on the population and existing risk factors.
-
The availability of a growing number of therapeutic options for acute stroke patients makes rapid and reliable diagnosis of stroke at the bedside more important than ever.
-
Noninferiority trials are usually designed to show that product B, which entered the therapeutic arena after product A, does not fall below a prespecified margin of efficacy compared to product A, ...
-
It has been a tough few months for marketers of vitamins and herbal products. Calcium plus vitamin D, saw palmetto, and glucosamine/chondroitin have all been the subject of studies that have questioned their efficacy.
-
Long-term use of warfarin is associated with an increase in osteoporotic fractures.
